Philippe Armand, MD, PhD, is the Chief of the Lymphoma Division and the Harold and Virginia Lash/David Lash Chair in Lymphoma Research at Dana-Farber Cancer Institute (DFCI), and an Associate Professor of Medicine at Harvard Medical School.

Dr. Armand’s research interests center on the treatment of lymphoma. His primary research focus is the study of immunotherapy to improve the efficacy of treatment and the outcome of patients with a variety of lymphoma types. Other areas of specific research interest are the study of CAR-T therapy in lymphoma and the development of next-generation assays to characterize, track and target tumors, especially aggressive B-cell non-Hodgkin Lymphomas and Hodgkin Lymphoma. After earning his Bachelor of Arts from Princeton University, Dr. Armand received his Doctor of Medicine and Doctor of Philosophy from the University of California at San Francisco. He completed his internship and residency at Brigham and Women’s Hospital, and fellowship training at DFCI.